13-year-old Terry Emmanuel Louise was at risk of heart failure as he was not able to get a heart transplant amid the COVID-19 pandemic. Our team at Gleneagles Global Health City, Chennai, successfully performed a left ventricular assist device (LVAD) implantation surgery, allowing Terry’s heart to keep functioning while he awaits a heart transplant.
Terry suffers from cardiomyopathy, a disease of the heart muscle which makes it harder for the heart to pump blood to the rest of the body, potentially leading to heart failure. He was repeatedly admitted to the hospital with symptoms of fluid overload which required inotropic infusion and intravenous diuretics.
As a heart transplant was not immediately possible amid the COVID-19 pandemic, the LVAD implant was the only option to prevent his condition from deteriorating further.
For this procedure, a ventricular assist device (VAD) was implanted in Terry’s left ventricle. It is a mechanical pump that supports heart function and blood flow for people with weakened hearts. It stimulates a healthy heart, taking blood from a lower chamber of the heart and pumping it to the body and vital organs.
With this implantation surgery, Terry’s heart is now able to continue functioning while he waits for a donor heart.
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Parkway Shanghai Opens International Centre for Hepatobiliary and Pancreatic Diseases
